For adults with extensive-stage small cell lung cancer (ES-SCLC) in combination with chemotherapy. See full indication »

I’M IN for first things first

CARING FOR SOMEONE WITH SCLC IS A BIG JOB. LEARN HOW TO MAKE IT MORE MANAGEABLE

If you’re caring for a loved one with ES-SCLC, you have the opportunity to give them the hope and confidence they need to get through treatment. You can do that many ways, from simply being there, to providing practical help and emotional support throughout the day.

AS A CAREGIVER, YOU MAY SUPPORT YOUR LOVED ONE WITH HELP FOR A VARIETY OF NEEDS—BOTH BIG AND SMALL—SUCH AS:

Calendar icon

Scheduling appointments

Bowling icon

Coordinating activities, such as game night and outings

Laundry icon

Help with chores or running errands

Healthcare team icon

Meeting the healthcare team and understanding each person’s role

Bag icon

Preparing them for infusion days

 

HOW SHOULD I COMMUNICATE WITH MY LOVED ONE?

Communicating with your loved one is one of the most important things you can do. To help you start a healthy and honest conversation with the person you care for, try these helpful tips:

Listening icon

Be a supportive listener—Try to find the right balance between knowing when to offer support and when to step in. Let your loved one open up, and listen to what he or she has to say before trying to fix things—this can give you a clearer picture of what’s really going on.

Helping icon

Help them have the tough conversations—There may be things your loved one is nervous or embarrassed (ie, relating to symptoms or side effects) about bringing up with the healthcare team, but remember that most doctors have heard or seen it all. Tell your loved one that it’s OK to bring up topics that are personal—the more their doctor knows, the more they can help.

Use the Doctor Discussion guide to get started.

 

TAKING CARE OF YOU! CHECK OUT A FEW SIMPLE GOOD SELF-CARE TIPS

Taking good care of yourself is critical in order to take good care of someone else. Here are some tips to help you practice some self-care:

Dog walking icon

Be mindful of stress and ways to reduce it—Take a walk outdoors, pet an animal, or listen to a favorite song that brings up happy memories.

Meditation icon

Take a break—Try using mind-clearing techniques like tai chi, meditation, yoga, or prayer to reduce your mental burden.

Selfcare icon

Nurture yourself—Getting proper rest and nutrition, reading a good book, or taking a warm bath can go a long way toward reducing tension.

For more tips on finding happiness in your everyday life, visit www.psychologytoday.com.

 

CONNECT AND LEARN MORE

American Cancer Society Find out what to expect if you become a caregiver for a person with cancer, and get tips for making sure that you take care of yourself as well. Learn more at www.cancer.org 800-227-2345

National Cancer Institute If you’re helping your family member or friend through cancer treatment, you are a caregiver who may be providing emotional and spiritual support. Learn more at www.cancer.gov 800-422-6237

 

Stay IN with IMFINZI—get more information, support, a downloadable Treatment Journal, and a Patient Starter Kit

SIGN UP FOR MORE SUPPORT
Financial support icon

Find out what financial support is available to you and the person you care for

SEE HOW IT WORKS

Important Safety Information

What is the most important information I should know about IMFINZI?

IMFINZI is a medicine that may treat a type of cancer in the bladder and urinary tract or certain types of lung cancer by working with your immune system.

IMFINZI can cause your immune system to attack normal organs and tissues and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death.

What is IMFINZI?IMFINZI® (durvalumab) SCLC page logo

IMFINZI® (durvalumab) is a prescription medicine used to treat adults with a type of lung cancer called small cell lung cancer (SCLC). IMFINZI may be used with the chemotherapy medicines etoposide and carboplatin or cisplatin as your first treatment when your SCLC has spread within your lungs or to other parts of the body (extensive-stage small cell lung cancer, or ES-SCLC).

It is not known if IMFINZI is safe and effective in children.

Call or see your healthcare provider right away if you develop any symptoms of the following problems or if these symptoms get worse:

  • Lung problems icon

    Lung problems (pneumonitis). Signs and symptoms may include new or worsening cough, shortness of breath, and chest pain.

  • Liver problems icon

    Liver problems (hepatitis). Signs and symptoms may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), drowsiness, dark urine (tea colored), bleeding or bruising more easily than normal, and feeling less hungry than usual.

  • Intestinal problems icon

    Intestinal problems (colitis). Signs and symptoms may include diarrhea or more bowel movements than usual; stools that are black, tarry, sticky, or have blood or mucus; and severe stomach-area (abdomen) pain or tenderness.

  • Hormone gland problems icon

    Hormone gland problems (especially the thyroid, adrenals, pituitary, and pancreas). Signs and symptoms that your hormone glands are not working properly may include headaches that will not go away or unusual headaches; extreme tiredness; weight gain or weight loss; dizziness or fainting; feeling more hungry or thirsty than usual; hair loss; feeling cold; constipation; your voice gets deeper; urinating more often than usual; nausea or vomiting; stomach-area (abdomen) pain; and changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness.

  • Kidney problems icon

    Kidney problems, including nephritis and kidney failure. Signs of kidney problems may include decrease in the amount of urine, blood in your urine, swelling of your ankles, and loss of appetite.

  • Skin problems icon

    Skin problems. Signs may include rash, itching, and skin blistering.

  • Other organ problems icon

    Problems in other organs. Signs and symptoms may include neck stiffness; headache; confusion; fever; chest pain, shortness of breath, or irregular heartbeat (myocarditis); severe or persistent muscle pain; severe muscle weakness; changes in mood or behavior; low red blood cells (anemia); excessive bleeding or bruising; blurry vision, double vision, or other vision problems; and eye pain or redness.

  • Severe infections icon

    Severe infections. Signs and symptoms may include fever, cough, frequent urination, pain when urinating, and flu-like symptoms.

  • Severe infusion reactions icon

    Severe infusion reactions. Signs and symptoms may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, fever, feeling like passing out, back or neck pain, and facial swelling.

Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may delay or completely stop treatment with IMFINZI if you have severe side effects.

Before you receive IMFINZI, tell your healthcare provider about all of your medical conditions, including if you have immune system problems such as Crohn’s disease, ulcerative colitis, or lupus; have had an organ transplant; have lung or breathing problems; have liver problems; or are being treated for an infection.

If you are pregnant or plan to become pregnant, tell your healthcare provider. IMFINZI can harm your unborn baby. If you are able to become pregnant, you should use an effective method of birth control during your treatment and for at least 3 months after the last dose of IMFINZI. Talk to your healthcare provider about which birth control methods to use. Tell your healthcare provider right away if you become pregnant during treatment with IMFINZI.

If you are breastfeeding or plan to breastfeed, tell your healthcare provider. It is not known if IMFINZI passes into breast milk. Do not breastfeed during treatment with IMFINZI and for at least 3 months after the last dose of IMFINZI.

Tell your healthcare provider about all the medicines you take. This includes prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of IMFINZI?

IMFINZI can cause serious side effects (see above).

The most common side effects of IMFINZI when used with other anticancer medicines with SCLC include: nausea, hair loss, and feeling tired or weak.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI. Ask your healthcare provider or pharmacist for more information.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

You may report side effects related to AstraZeneca products by clicking here.

What is IMFINZI?IMFINZI® (durvalumab) SCLC page logo

IMFINZI® (durvalumab) is a prescription medicine used to treat adults with a type of lung cancer called small cell lung cancer (SCLC). IMFINZI may be used with the chemotherapy medicines etoposide and carboplatin or cisplatin as your first treatment when your SCLC has spread within your lungs or to other parts of the body (extensive-stage small cell lung cancer, or ES-SCLC).

It is not known if IMFINZI is safe and effective in children.

Please see complete Prescribing Information, including Patient Information (Medication Guide).

+

Important Safety Information +

What is the most important information I should know about IMFINZI?

IMFINZI is a medicine that may treat a type of cancer in the bladder and urinary tract or certain types of lung cancer by working with your immune system.

IMFINZI can cause your immune system to attack normal organs and tissues and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death.

What is IMFINZI?IMFINZI® (durvalumab) SCLC page logo

IMFINZI® (durvalumab) is a prescription medicine used to treat adults with a type of lung cancer called small cell lung cancer (SCLC). IMFINZI may be used with the chemotherapy medicines etoposide and carboplatin or cisplatin as your first treatment when your SCLC has spread within your lungs or to other parts of the body (extensive-stage small cell lung cancer, or ES-SCLC).

It is not known if IMFINZI is safe and effective in children.